Coronary Heart Disease, Susceptibility to, 1
Conditions
Keywords
TRAF3IP2, Coronary angiography, coronary deart disease
Brief summary
To evaluate the association of surem TRAF3IP2 levels with the atherosclerotic plaque development in human
Detailed description
Previous study had concluded that TRAF3IP2 plays a causal role in atherosclerotic plaque development and vulnerability in mice. However, no human data was available. In the present study, patients who receive coronary angiography will be enrolled. Their surem TRAF3IP2 levels will be tested using ELASA. The association of surem TRAF3IP2 levels with the atherosclerotic plaque will be evaluated.
Interventions
OTHERNo intervention
This is an obvertional study, and there is no intervention.
Sponsors
Nanjing Medical University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
1. Patients with suspected coronary heart disease 2. patients received coronary angiography
Exclusion criteria
1. NYHA III-IV 2. malignant tumor 3. acute infection 4. thyroid dysfunction
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| stenosis of coronary artery | 1 week | The stenosis of coronary artery based on the results of coronary angiography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| coronary artery calcium | 1 week | The coronary artery calcification based on the results of coronary angiography |
Countries
China
Contacts
Primary ContactGeng Jin, MD
Outcome results
None listed